A study to characterise the safety, tolerability and efficacy of LY3962673 in subjects with advanced solid tumors.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516440-25-00

Acronym

J5J-OX-JZZA

Enrollment

170

Registered

2025-01-20

Start date

2025-02-06

Completion date

Unknown

Last updated

2025-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

KRAS G12D-mutant solid tumors.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Ireland, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026